Neurogene Company
Neurogene is a developer of genetic medicines intended to improve patient outcomes for neurological disorders.
Headquarters:
New York, New York, United States
Funding Status:
Early Stage Venture
Employee Number:
11-50
Estimated Revenue:
$10M to $50M
Investment Stage:
N/A
Number Of Exists:
N/A
Technology:
Neurological Disorders
Investor Type:
N/A
Founded Date:
2018
Industry:
Gene Therapy